If you’re among the 2.6 million active users of the popular telehealth apps Hims and Hers to obtain medication for erectile dysfunction, hair loss, and a cavalcade of other intimate issues, there’s probably a very short list of people you want to know about it — and Mark Zuckerberg probably isn’t one of them.
On Wednesday, the US Federal Trade Commission filed a major lawsuit against Hims and Hers, over allegations the firm was sharing user’s health information with third party companies, Gizmodo reported. Chief among those third-parties apps was Zuckerberg’s Meta, as well as Snap, two social media companies with horrible track records on protecting sensitive information.
Though Hims and Hers advertises its app-based health services as “100 percent online, private, and secure,” the FTC suit alleges “those assurances were false or misleading.”
“Instead of honoring its privacy promises,” the filing says, “Hims opted to grow the company and increase its revenue streams… with advertising platforms such as Meta and Snap.”
The suit doesn’t blame Meta directly, but argues that Hims and Hers used two “automated tracking technologies offered by Meta” to surveil users’ actions on the telehealth app. “These two tools automatically tracked and disclosed certain Events [user actions] to Meta,” the lawsuit reads.
Hims sells all kinds of men’s health meds, but most people know it for one thing: erectile dysfunction pills. While any leak of patient data would be an outrage, the thought that Hims could be sharing this particular kind of medical information is especially horrifying.
In a statement, Hims and Hers argued that the FTC’s case “is not enforcement grounded in consumer protection,” but rather “an effort to generate headlines at our expense.”
The lawsuit comes on the back of a three-year investigation by the FTC, and is currently in the very early stages — meaning it could be years before a final verdict is reached.
More on Meta: Meta’s Attempted Crackdown on AI Glasses Perverts Is Already Failing